Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Cetuximab can cause eyelash growth, which is rare but manageable.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Meis1 is crucial for skin health and tumor development.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.